Literature DB >> 32835590

Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health.

Arghya Mukherjee1, Cathy Lordan1,2, R Paul Ross2,3, Paul D Cotter1,3.   

Abstract

Over the last two decades our understanding of the gut microbiota and its contribution to health and disease has been transformed. Among a new 'generation' of potentially beneficial microbes to have been recognized are members of the genus n class="Species">Eubacterium, who form a part of the core human gut microbiome. The genus consists of phylogenetically, and quite frequently phenotypically, diverse species, making Eubacterium a taxonomically unique and challenging genus. Several members of the genus produce butyrate, which plays a critical role in energy homeostasis, colonic motility, immunomodulation and suppression of inflammation in the gut. Eubacterium spp. also carry out bile acid and cholesterol transformations in the gut, thereby contributing to their homeostasis. Gut dysbiosis and a consequently modified representation of Eubacterium spp. in the gut, have been linked with various human disease states. This review provides an overview of Eubacterium species from a phylogenetic perspective, describes how they alter with diet and age and summarizes its association with the human gut and various health conditions.

Entities:  

Keywords:  Eubacterium ; Eubacterium hallii ; Eubacterium rectale ; bile acids; butyrate; cholesterol; gut microbiota; irritable bowel syndrome; phylogeny; short-chain fatty acids

Year:  2020        PMID: 32835590      PMCID: PMC7524325          DOI: 10.1080/19490976.2020.1802866

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  188 in total

1.  Effect of feeding of a cholesterol-reducing bacterium, Eubacterium coprostanoligenes, to germ-free mice.

Authors:  L Li; S M Batt; M Wannemuehler; A Dispirito; D C Beitz
Journal:  Lab Anim Sci       Date:  1998-06

2.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Authors:  Henri Duboc; Sylvie Rajca; Dominique Rainteau; David Benarous; Marie-Anne Maubert; Elodie Quervain; Ginette Thomas; Véronique Barbu; Lydie Humbert; Guillaume Despras; Chantal Bridonneau; Fabien Dumetz; Jean-Pierre Grill; Joëlle Masliah; Laurent Beaugerie; Jacques Cosnes; Olivier Chazouillères; Raoul Poupon; Claude Wolf; Jean-Maurice Mallet; Philippe Langella; Germain Trugnan; Harry Sokol; Philippe Seksik
Journal:  Gut       Date:  2012-09-19       Impact factor: 23.059

3.  Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale.

Authors:  Darrell W Cockburn; Nicole I Orlovsky; Matthew H Foley; Kurt J Kwiatkowski; Constance M Bahr; Mallory Maynard; Borries Demeler; Nicole M Koropatkin
Journal:  Mol Microbiol       Date:  2014-12-19       Impact factor: 3.501

4.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Authors:  Rohit Loomba; Victor Seguritan; Weizhong Li; Tao Long; Niels Klitgord; Archana Bhatt; Parambir Singh Dulai; Cyrielle Caussy; Richele Bettencourt; Sarah K Highlander; Marcus B Jones; Claude B Sirlin; Bernd Schnabl; Lauren Brinkac; Nicholas Schork; Chi-Hua Chen; David A Brenner; William Biggs; Shibu Yooseph; J Craig Venter; Karen E Nelson
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

Review 5.  The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.

Authors:  Sabbir Khan; Gopabandhu Jena
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

Review 6.  Bile acid metabolism and signaling.

Authors:  John Y L Chiang
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

7.  Subsistence strategies in traditional societies distinguish gut microbiomes.

Authors:  Alexandra J Obregon-Tito; Raul Y Tito; Jessica Metcalf; Krithivasan Sankaranarayanan; Jose C Clemente; Luke K Ursell; Zhenjiang Zech Xu; Will Van Treuren; Rob Knight; Patrick M Gaffney; Paul Spicer; Paul Lawson; Luis Marin-Reyes; Omar Trujillo-Villarroel; Morris Foster; Emilio Guija-Poma; Luzmila Troncoso-Corzo; Christina Warinner; Andrew T Ozga; Cecil M Lewis
Journal:  Nat Commun       Date:  2015-03-25       Impact factor: 14.919

8.  High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects.

Authors:  Greta Jakobsdottir; Jie Xu; Göran Molin; Siv Ahrné; Margareta Nyman
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes.

Authors:  Moran Yassour; Mi Young Lim; Hyun Sun Yun; Timothy L Tickle; Joohon Sung; Yun-Mi Song; Kayoung Lee; Eric A Franzosa; Xochitl C Morgan; Dirk Gevers; Eric S Lander; Ramnik J Xavier; Bruce W Birren; GwangPyo Ko; Curtis Huttenhower
Journal:  Genome Med       Date:  2016-02-17       Impact factor: 11.117

10.  Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level.

Authors:  Douglas J Kenny; Damian R Plichta; Dmitry Shungin; Nitzan Koppel; A Brantley Hall; Beverly Fu; Ramachandran S Vasan; Stanley Y Shaw; Hera Vlamakis; Emily P Balskus; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2020-06-15       Impact factor: 21.023

View more
  39 in total

1.  Causal effects in microbiomes using interventional calculus.

Authors:  Musfiqur Sazal; Vitalii Stebliankin; Kalai Mathee; Changwon Yoo; Giri Narasimhan
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

2.  Tungsten enzymes play a role in detoxifying food and antimicrobial aldehydes in the human gut microbiome.

Authors:  Gerrit J Schut; Michael P Thorgersen; Farris L Poole; Dominik K Haja; Saisuki Putumbaka; Michael W W Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

3.  Expanding the genetic engineering toolbox for the metabolically flexible acetogen Eubacterium limosum.

Authors:  Patrick A Sanford; Benjamin M Woolston
Journal:  J Ind Microbiol Biotechnol       Date:  2022-10-13       Impact factor: 4.258

4.  Deciphering microbial gene function using natural language processing.

Authors:  Danielle Miller; Adi Stern; David Burstein
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

5.  Grape seed and skin extract, a potential prebiotic with anti-obesity effect through gut microbiota modulation.

Authors:  Mohamed Mokrani; Kamel Charradi; Ferid Limam; Ezzedine Aouani; Maria C Urdaci
Journal:  Gut Pathog       Date:  2022-07-06       Impact factor: 5.324

6.  Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism.

Authors:  Xinyi Fang; Haoran Wu; Xinmiao Wang; Fengmei Lian; Min Li; Runyu Miao; Jiahua Wei; Jiaxing Tian
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 7.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

8.  Cord blood metabolites and rapid postnatal growth as multiple mediators in the prenatal propensity to childhood overweight.

Authors:  Rossella Alfano; Michelle Plusquin; Oliver Robinson; Sonia Brescianini; Lida Chatzi; Pekka Keski-Rahkonen; Evangelos Handakas; Lea Maitre; Tim Nawrot; Nivonirina Robinot; Theano Roumeliotaki; Franco Sassi; Augustin Scalbert; Martine Vrijheid; Paolo Vineis; Lorenzo Richiardi; Daniela Zugna
Journal:  Int J Obes (Lond)       Date:  2022-05-04       Impact factor: 5.551

Review 9.  Gut Serpinome: Emerging Evidence in IBD.

Authors:  Héla Mkaouar; Vincent Mariaule; Soufien Rhimi; Juan Hernandez; Aicha Kriaa; Amin Jablaoui; Nizar Akermi; Emmanuelle Maguin; Adam Lesner; Brice Korkmaz; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 10.  Lights and Shadows of Microbiota Modulation and Cardiovascular Risk in HIV Patients.

Authors:  Pablo Villoslada-Blanco; Patricia Pérez-Matute; José A Oteo
Journal:  Int J Environ Res Public Health       Date:  2021-06-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.